Bringing together experts from across disciplines, ESC Cardio-Oncology 2026 will foster collaboration, inspire innovation and help shape the future of cardio-oncology care.
The ESC Cardio-Oncology 2026, the annual conference of the ESC Council of Cardio-Oncology, will take place in Vienna on 19–20 June and bring together leading clinicians, researchers, healthcare professionals and industry representatives working at the forefront of the field.
For the COMPASS project, the event provides an important platform to share knowledge, engage with the wider cardio-oncology community and contribute to discussions shaping the future of cardiovascular health in oncology. Bringing together European and international specialists from cardiology, oncology, haematology, radiotherapy and related disciplines, ESC Cardio-Oncology 2026 will provide a unique forum for exchanging expertise, addressing emerging challenges and exploring innovative approaches to patient care.
As a project dedicated to optimising the cardiovascular health of cancer patients and survivors through a comprehensive, patient-centred approach, COMPASS is closely aligned with many of the themes that will be explored throughout the event. From early cardiotoxicity risk prediction and advanced imaging technologies to AI-driven decision support and long-term survivorship care, the conference reflects several of the priorities currently being addressed within the project.
The COMPASS consortium looks forward to the valuable discussions, scientific exchanges and insights that will emerge from ESC Cardio-Oncology 2026, contributing to ongoing efforts to advance cardiovascular care for cancer patients and survivors across Europe.
